Sign In
NewsRadar

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.

   


Bioceros B.V. announces change of ownership


Utrecht, The Netherlands, February 17th, 2011 - Bioceros B.V. announces that it has successfully realized a change of ownership. This is the result of the purchase of the outstanding shares owned by Forbion, Thuja Capital and Biogeneration Ventures by existing shareholders and the management team.

Bioceros’ CEO, Dr. Bram Bout comments: “The financial round of 2008, which was led by Thuja Capital and Biogeneration Ventures, has allowed us to build a strong, independent service business and to lay the foundation for a product pipeline. We are therefore pleased and proud that we can offer our investors this exit. Bioceros will further grow its service business by expanding its technology platform and spin out its early-stage products in a separate legal entity.”

Dr. Mark de Boer (chairman) and Dr. Oscar Schoots, MBA, will remain members of the Supervisory Board of Bioceros.

About Bioceros.

Bioceros is a biotech company focusing on pre-clinical development of protein products, with an emphasis on monoclonal antibodies. Bioceros’ technology platform covers early pre-clinical development of monoclonal antibodies, including generation of monoclonal antibodies in mice, making high protein producing CHO and PER.C6® cell lines, assay development and pre-clinical manufacturing at 20L scale. This is all Quality Controlled, using state of the art serum-free culture media, such that the generated cell lines can be used for GMP manufacturing. Bioceros is preferred vendor of DSM Biologics and Crucell for PER.C6® cell line generation services.
Bioceros uses this technology platform to offer services to the industry and academia, and to develop its own pipeline of monoclonal antibody products.

Bioceros is located in Utrecht, the Netherlands. For more information, please visit www.bioceros.com or contact:


Remco M. Brandt
COO
Bioceros BV
Yalelaan 46
3584 CM UTRECHT
The Netherlands

Phone: +31(0) 30-253 7910
Cell: +31(0) 6-1012 7709
Fax: +31(0) 30-253 2288
URL: www.bioceros.com


Publisher Contact Information:

Bioceros
+31(0) 30-253 7910
-

Company profile of Bioceros
Past press releases of Bioceros.

Data


19,837
Tech investments
From our Online Data Service
12,786
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
Apr 18€8.0MInternet commerce
Apr 16€10.0MPayment software
Apr 16€10.0MPayment software
Apr 15€6.0MInternet commerce
Apr 15€4.0MConsumer electronics
Apr 14N/AInternet commerce
Apr 14€3.5MNetwork management

For information on Europe's most extensive database on technology funding click here!

Events


Cleantech Forum Europe 2015
April 27 - 29, 2015

EVCA CFO Forum
June 2 - 3, 2015

BIO-Europe 2015
November 2 - 4, 2015


Press Releases


Apr 20
Dealerdirect
dealerdirect, the online marketplace for second-hand vehicles in eu...

Apr 16
Wilson Therapeutics
wilson therapeutics announces presentation of wtx101-201 phase 2 st...

Apr 14
Rethink
rethink group bolsters its talent management offering with the acqu...

Apr 14
Onbone (Woodcast)
onbone ltd raises €10m from international investor syndicate for th...

Apr 14
Movidius (formerly Movidia)
movidius raises $40 million in funding to accelerate adoption of vi...





About usContact usLegal Information
Copyright © 1999-2015
Emerging Technology Research Europe Inc. All rights reserved.